Skip to main content

3 Result(s)

within Qiaoqiao Shu Remove this filter

and

  1. No Access

    Article

    Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis

    Recent studies have shown the potential of fibroblast activating protein inhibitor (FAPI) PET imaging for pancreatic cancer assessment.

    Ranbie Tang, Mengna Liu, Qiaoqiao Shu, ** Chen, Liang Cai in European Radiology (2024)

  2. No Access

    Article

    Comparison of [18F]FDG and [68 Ga]pentixafor PET/CT in Nasopharyngeal Carcinoma

    This study aimed to explore the feasibility of [68 Ga]pentixafor positron emission tomography/computed tomography (PET/CT) in patients with nasopharyngeal carcinoma (NPC).

    Mengna Liu, ** Chen, Haoyuan Ding, Qiaoqiao Shu, Yun Zheng… in Molecular Imaging and Biology (2024)

  3. No Access

    Article

    The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG

    [18F]FDG PET/CT to detect unknown primary lesions is essential for clinical management but still has limitations. [68Ga]Ga-FAPI is a tumor-stromal imaging agent that provides a promising alternative to [18F]FD...

    Qiaoqiao Shu, Maoxue Deng, Mei Hu… in European Journal of Nuclear Medicine and M… (2023)